source
- Experts see Replimune’s Tudriqev approval as a step toward broader use of localized cancer therapiesReplimune received FDA approval last month for Tudriqev, an oncolytic virus injected directly into melanoma tumors, marking only the second such approval for a therapy delivered straight into a tum…
- Transposase-based cell line platform speeds development and raises protein yields for complex biologicsAdvanced cell line development tools are helping biopharma tackle the expression and stability challenges of increasingly complex molecules such as bispecifics and trispecifics. The article highli…